Cardio Diagnostics Holdings, Inc. Files 8-K

Ticker: CDIOW · Form: 8-K · Filed: Apr 2, 2024 · CIK: 1870144

Cardio Diagnostics Holdings, Inc. 8-K Filing Summary
FieldDetail
CompanyCardio Diagnostics Holdings, Inc. (CDIOW)
Form Type8-K
Filed DateApr 2, 2024
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.00001
Sentimentneutral

Sentiment: neutral

Topics: 8-K, regulatory-disclosure, financials

Related Tickers: CDIO

TL;DR

CDIO filed an 8-K on April 2nd covering Reg FD and financials. No major news, just routine updates.

AI Summary

On April 2, 2024, Cardio Diagnostics Holdings, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. The company, previously known as Mana Capital Acquisition Corp., changed its name on June 29, 2021. Its principal executive offices are located at 311 W. Superior Street, Suite 444, Chicago, IL 60645.

Why It Matters

This 8-K filing provides updates on the company's regulatory disclosures and financial statements, which are important for investors to understand the company's current status and compliance.

Risk Assessment

Risk Level: low — The filing is a routine 8-K report detailing financial statements and regulatory disclosures, with no immediate indication of significant new risks or events.

Key Players & Entities

  • Cardio Diagnostics Holdings, Inc. (company) — Registrant
  • Mana Capital Acquisition Corp. (company) — Former company name
  • April 2, 2024 (date) — Date of report
  • June 29, 2021 (date) — Date of name change
  • 311 W. Superior Street, Suite 444, Chicago, IL 60645 (location) — Business address

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is for Regulation FD Disclosure and to report Financial Statements and Exhibits.

When was Cardio Diagnostics Holdings, Inc. previously known by another name?

Cardio Diagnostics Holdings, Inc. was previously known as Mana Capital Acquisition Corp., with the name change occurring on June 29, 2021.

What is the business address of Cardio Diagnostics Holdings, Inc.?

The business address of Cardio Diagnostics Holdings, Inc. is 311 W. Superior Street, Suite 444, Chicago, IL 60645.

What is the fiscal year end for Cardio Diagnostics Holdings, Inc.?

The fiscal year end for Cardio Diagnostics Holdings, Inc. is December 31st (1231).

What is the SIC code for Cardio Diagnostics Holdings, Inc.?

The Standard Industrial Classification (SIC) code for Cardio Diagnostics Holdings, Inc. is 2835, which pertains to IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES.

Filing Stats: 589 words · 2 min read · ~2 pages · Grade level 10.5 · Accepted 2024-04-02 16:30:47

Key Financial Figures

  • $0.00001 — ch registered Common Stock, par value $0.00001 CDIO The Nasdaq Stock Market LLC

Filing Documents

01

Item 7.01. Regulation FD Disclosure Effective April 3, 2024, senior management of Cardio Diagnostics Holdings Inc. (the "Company") will begin using the materials included in Exhibit 99.1 to this report (the "Investor Presentation") in connection with presentations to existing and prospective investors. The Investor Presentation is incorporated into this Item 7.01 by this reference and will also be available on the Company's website at www.cardiodiagnosticsinc.com

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description of Exhibit 99.1 Cardio Diagnostics Holdings Inc. March 2024 Investor Presentation. 104 Cover Page Interactive Data File - the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. THE INFORMATION CONTAINED IN ITEM 7.01 OF THIS CURRENT REPORT, INCLUDING EXHIBIT 99.1 ATTACHED HERETO, SHALL NOT BE DEEMED "FILED" FOR THE PURPOSES OF SECTION 18 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED, NOR SHALL IT BE DEEMED INCORPORATED BY REFERENCE INTO ANY REGISTRATION SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: April 2, 2024 CARDIO DIAGNOSTICS HOLDINGS INC. By: /s/ Elisa Luqman Elisa Luqman Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.